R. de Paz

651 total citations
22 papers, 270 citations indexed

About

R. de Paz is a scholar working on Hematology, Oncology and Rheumatology. According to data from OpenAlex, R. de Paz has authored 22 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 5 papers in Oncology and 4 papers in Rheumatology. Recurrent topics in R. de Paz's work include Acute Myeloid Leukemia Research (3 papers), Multiple Myeloma Research and Treatments (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). R. de Paz is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Multiple Myeloma Research and Treatments (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). R. de Paz collaborates with scholars based in Spain, Chile and Argentina. R. de Paz's co-authors include F. Hernández‐Navarro, Antonio Pérez‐Martínez, A. Balas, Elisa Luño, Benet Nomdedeu, Guillermo Sanz, Teresa Bernal, Lucía Fernández, David Valcárcel and E Oyarzún and has published in prestigious journals such as Clinical Infectious Diseases, Cancer Letters and Leukemia.

In The Last Decade

R. de Paz

21 papers receiving 256 citations

Peers

R. de Paz
Kazuo Hatanaka Japan
Ryoko Yamasaki Japan
Giulio Trapè Italy
Smeeta Gajendra India
KW Chik Hong Kong
Larisa Broglie United States
Arzu Akçay Türkiye
Vasiliki Vlacha Greece
L. S. Zubarovskaya Russia
Sophie Ducastelle France
Kazuo Hatanaka Japan
R. de Paz
Citations per year, relative to R. de Paz R. de Paz (= 1×) peers Kazuo Hatanaka

Countries citing papers authored by R. de Paz

Since Specialization
Citations

This map shows the geographic impact of R. de Paz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. de Paz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. de Paz more than expected).

Fields of papers citing papers by R. de Paz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. de Paz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. de Paz. The network helps show where R. de Paz may publish in the future.

Co-authorship network of co-authors of R. de Paz

This figure shows the co-authorship network connecting the top 25 collaborators of R. de Paz. A scholar is included among the top collaborators of R. de Paz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. de Paz. R. de Paz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bedoya, C. Fernandez, D. Eliseev, D. Francia Ferrero, et al.. (2025). OBDT-theta, a multi-channel TDC and readout board for the CMS muon drift tubes in HL-LHC. 3.
2.
Ferreras, Cristina, R. de Paz, José L. Vicário, et al.. (2021). SARS-CoV-2-Specific Memory T Lymphocytes From COVID-19 Convalescent Donors: Identification, Biobanking, and Large-Scale Production for Adoptive Cell Therapy. Frontiers in Cell and Developmental Biology. 9. 620730–620730. 31 indexed citations
3.
Vela, María, Paula Carrasco, Lucía Fernández, et al.. (2018). Haploidentical IL-15/41BBL activated and expanded natural killer cell infusion therapy after salvage chemotherapy in children with relapsed and refractory leukemia. Cancer Letters. 422. 107–117. 49 indexed citations
4.
Ramos, Fernando, Carme Pedro, Mar Tormo, et al.. (2016). Impact of anaemia on health-related quality of life and cardiac remodelling in patients with lower risk myelodysplastic syndromes. Results of GlobQoL study. European Journal of Cancer Care. 26(6). e12426–e12426. 2 indexed citations
5.
Bernal, Teresa, Pablo Martínez‐Camblor, Joaquín Sánchez‐García, et al.. (2015). Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: results from the Spanish registry. Leukemia. 29(9). 1875–1881. 67 indexed citations
6.
Noël, Nicolas, A. Drier, B. Wechsler, et al.. (2013). Manifestations neurologiques de la maladie de Behçet. La Revue de Médecine Interne. 35(2). 112–120. 17 indexed citations
7.
González‐Porras, José Ramón, Esperanza Such, Benet Nomdedeu, et al.. (2011). The degree of neutropenia has a prognostic impact in low risk myelodysplastic syndrome. Leukemia Research. 36(3). 287–292. 17 indexed citations
8.
Morado, Marta & R. de Paz. (2011). Anemia megaloblástica y gastritis atrófica. Revista Española de Enfermedades Digestivas. 103(6). 332–332. 2 indexed citations
9.
Rosiñol, Laura, José Antônio Baddini Martínez, MV Mateos, et al.. (2009). A160 Thalidomide/Dexamethasone (TD) Versus Bortezomib (Velcade)/Thalidomide/Dexamethasone (VTD) Versus VB. Clinical Lymphoma & Myeloma. 9. S26–S26. 2 indexed citations
10.
Mateos, MV, Yolanda González, Juan José Lahuerta, et al.. (2009). A154 Bortezomib (Velcade)/Melphalan/Prednisone (VMP) Versus Velcade/Thalidomide/Prednisone (VTP) in Elderly. Clinical Lymphoma & Myeloma. 9. S25–S25. 1 indexed citations
11.
Hill, Anita, Eric Van Den Neste, Petra Muus, et al.. (2008). Improvement in Fatigue With Eculizumab Treatment of Patients With Paroxysmal Nocturnal Hemoglobinuria (pnh) Occurs Independent of Changes in Anemia. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 93. 359–359. 3 indexed citations
12.
Muus, Petra, Eric Van Den Neste, Ulrich Duehrsen, et al.. (2007). The clinical benefit of eculizumab is demonstrable in all subpopulations of patients with paroxysmal nocturnal hemoglobinuria (PNH) with hemolysis. 92. 137–138. 1 indexed citations
13.
Paz, R. de & F. Hernández‐Navarro. (2006). [Management, prevention and control of pernicious anemia].. PubMed. 20(6). 433–5. 1 indexed citations
14.
Paz, R. de, et al.. (2006). [Therapeutic recommendations in the oncohematological patient].. PubMed. 21(3). 379–85. 7 indexed citations
15.
Paz, R. de & F. Hernández‐Navarro. (2005). Manejo, prevención y control del síndrome anémico secundario a deficiencia férrica. Nutrición Hospitalaria. 20(5). 364–367. 3 indexed citations
16.
Paz, R. de & F. Hernández‐Navarro. (2005). Manejo, prevención y control de la anemia perniciosa. Nutrición Hospitalaria. 20(6). 433–435. 3 indexed citations
17.
Paz, R. de, et al.. (2005). [Management, prevention and control of anaemia secondary to iron deficiency].. PubMed. 20(5). 364–7. 1 indexed citations
18.
Candela, Carmen Gómez, et al.. (2002). Soporte nutricional en el trasplante de médula ósea. Dialnet (Universidad de la Rioja). 307–319. 1 indexed citations
19.
Arredondo-Garcı́a, José Luis, Víctor Díaz, Hernando Gaitán, et al.. (1997). Oral Clindamycin and Ciprofloxacin Versus Intramuscular Ceftriaxone and Oral Doxycycline in the Treatment of Mild-to-Moderate Pelvic Inflammatory Disease in Outpatients. Clinical Infectious Diseases. 24(2). 170–178. 38 indexed citations
20.
Weiner, P, et al.. (1995). Severe aplastic anemia due to ticlopidine.. PubMed. 31(7). 444–5. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazuo Hatanaka Breakdown of academic impact, for papers by Ryoko Yamasaki Breakdown of academic impact, for papers by Giulio Trapè Breakdown of academic impact, for papers by Smeeta Gajendra Breakdown of academic impact, for papers by KW Chik Breakdown of academic impact, for papers by Larisa Broglie Breakdown of academic impact, for papers by Arzu Akçay Breakdown of academic impact, for papers by Vasiliki Vlacha Breakdown of academic impact, for papers by L. S. Zubarovskaya Breakdown of academic impact, for papers by Sophie Ducastelle
Rankless by CCL
2026